# Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance

> **NCT01093677** · PHASE1 · WITHDRAWN · sponsor: **Limerick BioPharma** · enrollment: 30 (estimated)

## Conditions studied

- Impaired Glucose Tolerance

## Interventions

- **DRUG:** LIM-0705
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01093677
- **Lead sponsor:** Limerick BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** no subjects enrolled
- **Last updated:** 2010-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093677, "Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01093677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*